Christopher Gibson, Director at RECURSION PHARMACEUTICALS, INC. (RXRX), sold 50,364 shares at $4.12 ($202K) on 2026-02-04, disclosed to the SEC on 2026-02-06.
Seasonal sale ($202k) by Director — this insider has traded RXRX in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.12 | 40,000 | $165K | 81.7% |
| 2 | $3.56 | 10,364 | $37K | 18.3% |
| Total | $4.00 avg | 50,364 | $202K | 100% |
| Filing → |
| RXRX | SELL | 2026-05-08 | $135K | — | Filing → |
| RXRX | SELL | 2026-04-24 | $144K | — | Filing → |
| RXRX | SELL | 2026-04-08 | $124K | — | Filing → |